{"id":"W2902552969","doi":"10.1182/blood-2018-09-876805","title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":378,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Adverse effect; Hemoglobinuria; Internal medicine; Lactate dehydrogenase; Clinical endpoint; Hemolysis; Gastroenterology; Clinical trial; Immunology; Complement system; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001275373,0.0005833724,0.00117115,0.0001423148,0.0001838365,0.0005540412,0.000378617,0.0005954232,0.001923806],"category_scores_gemma":[0.0008255344,0.0002562116,0.001043913,0.0001372342,0.0003343962,0.0004547583,0.0002067195,0.001238036,0.0003216858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003829538,"about_ca_system_score_gemma":0.0004923776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006306028,"about_ca_topic_score_gemma":0.001378491,"domain_scores_codex":[0.9995573,0.0003006183,0.00002402,0.00004584776,0.00002999266,0.00004205358],"domain_scores_gemma":[0.9995011,0.0001408364,0.00009585048,0.00002464044,0.00002255571,0.0002150651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9093135,0.01127389,0.0071678,0.0004567205,0.001698548,0.000149661,0.00012996,0.0009944959,0.01259072,0.0002017996,0.001580778,0.05444226],"study_design_scores_gemma":[0.5171018,0.4363517,0.03769452,0.00009870457,0.001244971,0.0002755629,0.0001028395,0.003007316,0.001566834,0.000219851,0.002298793,0.00003707519],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954567,0.003023328,0.0001375111,0.0001889855,0.00008505647,0.0002010622,0.0001704589,0.00001259712,0.0007243851],"genre_scores_gemma":[0.9969234,0.00138923,0.0002352241,0.0002843493,0.0001559952,0.0001605517,0.0002920164,0.000003521685,0.0005557088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001923806,"threshold_uncertainty_score":0.006744921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006469923226486906,"score_gpt":0.2262602937391997,"score_spread":0.2197903705127128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}